Cargando…
Promising Therapy Candidates for Liver Fibrosis
Liver fibrosis is a wound-healing process in response to repeated and chronic injury to hepatocytes and/or cholangiocytes. Ongoing hepatocyte apoptosis or necrosis lead to increase in ROS production and decrease in antioxidant activity, which recruits inflammatory cells from the blood and activate h...
Autores principales: | Wang, Ping, Koyama, Yukinori, Liu, Xiao, Xu, Jun, Ma, Hsiao-Yen, Liang, Shuang, Kim, In H., Brenner, David A., Kisseleva, Tatiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754444/ https://www.ncbi.nlm.nih.gov/pubmed/26909046 http://dx.doi.org/10.3389/fphys.2016.00047 |
Ejemplares similares
-
The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
por: Liang, Shuang, et al.
Publicado: (2016) -
The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies
por: Xu, Jun, et al.
Publicado: (2014) -
The role of human cytochrome P450 2E1 in liver inflammation and fibrosis
por: Xu, Jun, et al.
Publicado: (2017) -
Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
por: Chen, Li, et al.
Publicado: (2018) -
The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
por: Fuji, Hiroaki, et al.
Publicado: (2021)